Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Akiko Miyagi-Maeshima"'
Autor:
Tomotaka Suzuki, Dai Maruyama, Akiko Miyagi‐Maeshima, Junko Nomoto, Kinuko Tajima, Yuta Ito, Shunsuke Hatta, Sayako Yuda, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Hirokazu Taniguchi, Koji Izutsu, Yukio Kobayashi, Kensei Tobinai
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5101-5109 (2021)
Abstract Background Approximately 15% of patients with diffuse large B‐cell lymphoma (DLBCL) experience refractory or early relapsed disease after initial rituximab‐containing chemoimmunotherapy is regarded as a primary refractory disease. Althou
Externí odkaz:
https://doaj.org/article/6c9fedcd3a36413f9569e5dd522429e1
Autor:
Hajime Takamori, Akiko Miyagi Maeshima, Ikuma Kato, Masaya Baba, Eijiro Nakamura, Yoshiyuki Matsui
Publikováno v:
IJU Case Reports, Vol 6, Iss 3, Pp 161-164 (2023)
Introduction Renal cell carcinoma with TFEB amplification is rare and reportedly aggressive. We herein report a case of renal cell carcinoma with TFEB translocation and amplification in which long‐term control was achieved by multimodal therapy inc
Externí odkaz:
https://doaj.org/article/8119c804bb6242128b77397f7c809e39
Autor:
Takahiro Fujino, Dai Maruyama, Akiko‐Miyagi Maeshima, Yo Saito, Hanae Ida, Rika Hosoba, Sayako Yuda, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Tatsuya Suzuki, Junya Kuroda, Koji Izutsu
Publikováno v:
Cancer Medicine, Vol 11, Iss 10, Pp 2106-2116 (2022)
Abstract Watchful waiting (WW) is one of the standard approaches for newly diagnosed follicular lymphoma (FL) patients with low‐tumor burden. However, the impact of WW in FL patients at the first progression, remains unclear. We reviewed 206 FL pat
Externí odkaz:
https://doaj.org/article/b0e85bf5f2b24759b9f9076d79d6f745
Autor:
Mao Fujimoto, Eri Arai, Koji Tsumura, Takuya Yotani, Yuriko Yamada, Yoriko Takahashi, Akiko Miyagi Maeshima, Hiroyuki Fujimoto, Teruhiko Yoshida, Yae Kanai
Publikováno v:
Epigenetics, Vol 15, Iss 12, Pp 1289-1301 (2020)
The aim of this study was to develop a less invasive and accurate diagnostic system for upper urinary tract urothelial carcinoma (UTUC) based on genome-wide DNA methylation profiling. Genome-wide DNA methylation screening was performed using the Infi
Externí odkaz:
https://doaj.org/article/70a19411380d48a0a25d5ffd67febf54
Autor:
Ritsuko Nakai, Suguru Fukuhara, Akiko Miyagi Maeshima, Sung‐Won Kim, Yuta Ito, Shunsuke Hatta, Tomotaka Suzuki, Sayako Yuda, Shinichi Makita, Wataru Munakata, Tatsuya Suzuki, Dai Maruyama, Koji Izutsu
Publikováno v:
Clinical Case Reports, Vol 7, Iss 12, Pp 2500-2504 (2019)
Abstract This is the first case report of alectinib as a bridge to allo‐SCT in a patient with ALK‐positive ALCL refractory to both conventional chemotherapies and BV. This report offers a ray of hope for a condition with poor prognosis.
Externí odkaz:
https://doaj.org/article/1146156fd4824a3ea995b07729d80109
Autor:
Yoshikazu Hori, Yu Aruga, Chiaki Ikeda, Akiko Miyagi Maeshima, Koji Izutsu, Hiromichi Matsushita
Publikováno v:
eJHaem, Vol 3, Iss 1, Pp 239-240 (2022)
Externí odkaz:
https://doaj.org/article/d02b4b721c354fd081938f6bf7924e11
Autor:
Akiko Miyagi Maeshima, Hirokazu Taniguchi, Haruhi Furukawa, Daiki Hattori, Hirokazu Sasaki, Shinichi Makita, Noriko Iwaki, Suguru Fukuhara, Wataru Munakata, Koji Izutsu
Publikováno v:
Human Pathology. 135:84-92
Autor:
Hajime Takamori, Akiko Miyagi Maeshima, Ikuma Kato, Masaya Baba, Eijiro Nakamura, Yoshiyuki Matsui
Publikováno v:
IJU Case Reports. 6:161-164
Autor:
Akiko Miyagi Maeshima
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 63:12-18
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 674-675 (2021)
Externí odkaz:
https://doaj.org/article/456a42503cf14170ab044bfe5972f685